SARS-CoV-2 IgM Positive Serum

<strong>SARS-CoV-2 IgM Positive Serum</strong>_x000D_ <strong>Catalog number:</strong> B2010709_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Serum_x000D_ <strong>Applications:</strong> versatile molecular tool in the research and development of assays involving SARS-CoV-2_x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> SARS-CoV-2 IgM serum_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, Qian S, Hong C, Wang F, Liu Y, Wang Z, He Q, Li Z, He B, Zhang T, Fu Y, Ge S, Liu L, Zhang J, Xia N, Zhang Z. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019 Clin Infect Dis. 2020 Nov 19;71(16):2027-2034._x000D_ 2: Lee YL, Liao CH, Liu PY, Cheng CY, Chung MY, Liu CE, Chang SY, Hsueh PR. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients J Infect. 2020 Aug;81(2):e55-e58._x000D_ 3: Rostami A, Sepidarkish M, Leeflang MMG, Riahi SM, Nourollahpour Shiadeh M, Esfandyari S, Mokdad AH, Hotez PJ, Gasser RB. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis Clin Microbiol Infect. 2021 Mar;27(3):331-340._x000D_ 4: Post N, Eddy D, Huntley C, van Schalkwyk MCI, Shrotri M, Leeman D, Rigby S, Williams SV, Bermingham WH, Kellam P, Maher J, Shields AM, Amirthalingam G, Peacock SJ, Ismail SA. Antibody response to SARS-CoV-2 infection in humans: A systematic review PLoS One. 2020 Dec 31;15(12):e0244126._x000D_ 5: Anka AU, Tahir MI, Abubakar SD, Alsabbagh M, Zian Z, Hamedifar H, Sabzevari A, Azizi G. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management Scand J Immunol. 2021 Apr;93(4):e12998._x000D_ 6: Formiga FR, Leblanc R, de Souza Rebouças J, Farias LP, de Oliveira RN, Pena L. Ivermectin: an award-winning drug with expected antiviral activity against COVID-19 J Control Release. 2021 Jan 10;329:758-761._x000D_ 7: Li K, Huang B, Wu M, Zhong A, Li L, Cai Y, Wang Z, Wu L, Zhu M, Li J, Wang Z, Wu W, Li W, Bosco B, Gan Z, Qiao Q, Wu J, Wang Q, Wang S, Xia X. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19 Nat Commun. 2020 Nov 27;11(1):6044._x000D_ 8: Islam KU, Iqbal J. An Update on Molecular Diagnostics for COVID-19 Front Cell Infect Microbiol. 2020 Nov 10;10:560616._x000D_ 9: Song KH, Kim DM, Lee H, Ham SY, Oh SM, Jeong H, Jung J, Kang CK, Park JY, Kang YM, Kim JY, Park JS, Park KU, Kim ES, Kim HB. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19 Korean J Intern Med. 2021 Jan;36(1):11-14._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33872783">10: Hansen T, Titze U, Kulamadayil-Heidenreich NSA, Glombitza S, Tebbe JJ, Röcken C, Schulz B, Weise M, Wilkens L. First case of postmortem study in a patient vaccinated against SARS-CoV-2 Int J Infect Dis. 2021 Jun;107:172-175. </a>_x000D_ _x000D_ <strong>Products Related to SARS-CoV-2 IgM Positive Serum</strong><a href="https://moleculardepot.com/product-category/serum-plasma/">: Serum &amp; Plasma</a>